![Jeffrey Arcara](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey Arcara
Corporate Officer/Principal en CORVUS PHARMACEUTICALS, INC. .
Fortuna: - $ al 31/05/2024
Origen de la red de primer grado Jeffrey Arcara.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 11 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jeffrey Arcara a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
PHARMACYCLICS, INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
RESPONSE BIOMEDICAL CORP | Miscellaneous Commercial Services | Chairman | |
Plexxikon, Inc.
![]() Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chief Executive Officer | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Cardioxyl Pharmaceuticals LLC
![]() Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | Director/Board Member | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Founder Chairman | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal | |
SGX Pharmaceuticals, Inc.
![]() SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder | |
Newyu, Inc.
![]() Newyu, Inc. Medical/Nursing ServicesHealth Services Newyu, Inc. provides web-based health information services. It offers implementation, ongoing account management and customer support services. The company serves those monitoring asthma, diabetes, pulmonary disease, hypertension, cardiovascular disease and congestive heart failure. iMetrikus was founded by William J. Rutter in 1998 and is headquartered in Carlsbad, CA. | Medical/Nursing Services | Chief Executive Officer | |
Wilson Sonsini Goodrich & Rosati PC
![]() Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | General Counsel | |
MIRATI THERAPEUTICS | Biotechnology | Director/Board Member | |
OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
InterWest Partners LLC
![]() InterWest Partners LLC Investment ManagersFinance InterWest Partners LLC (InterWest Partners) is a venture capital firm founded in 1979 by Wally Hawley, Scott Hedrick and Gene Barth. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Yale University | College/University | Undergraduate Degree | |
University of Cincinnati (Ohio) | College/University | Doctorate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
BD Biosciences, Systems & Reagents, Inc.
![]() BD Biosciences, Systems & Reagents, Inc. Pharmaceuticals: MajorHealth Technology BD Biosciences, Systems & Reagents, Inc. provides tools and solutions to research and clinical laboratories in basic research, drug discovery, development, biopharmaceutical production and disease management. The company was founded on May 9, 1991 and is headquartered in San Jose, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The J. David Gladstone Institutes
![]() The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services The J. David Gladstone Institutes operates as an independent state-of-the-art biomedical research institution. The company was founded in 1979 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
ARCA BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Adaptimmune Ltd.
![]() Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Strategicon Partners | Founder | ||
Cleave Therapeutics, Inc.
![]() Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Founder | |
Stanford Law School | College/University | Graduate Degree | |
Yale School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
The Warren Alpert Medical School | College/University | Doctorate Degree | |
OxOnc Development LP
![]() OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Biotechnology | Director/Board Member | |
SYNTHORX, INC. | Biotechnology | Director/Board Member | |
PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ReCode Therapeutics, Inc.
![]() ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
Sanofi Corp. | General Counsel | ||
ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member | |
PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
EDGEWISE THERAPEUTICS, INC. | Biotechnology | Founder | |
California Life Sciences Association
![]() California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
TARSUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Angel Pharmaceuticals Co., Ltd.
![]() Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Gennao Bio, Inc.
![]() Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
Terremoto Biosciences, Inc.
![]() Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 45 |
Reino Unido | 3 |
Canadá | 2 |
Hong-Kong | 2 |
Islas Caimán | 2 |
Sectorial
Health Technology | 32 |
Commercial Services | 8 |
Consumer Services | 8 |
Health Services | 3 |
Finance | 2 |
Operativa
Director/Board Member | 99 |
Independent Dir/Board Member | 43 |
Corporate Officer/Principal | 31 |
Founder | 17 |
Chairman | 12 |
Las relaciones más conectadas
Insiders | |
---|---|
Peter Thompson | 39 |
Ian Clark | 35 |
Terry Gould | 26 |
Linda Grais | 20 |
Scott Morrison | 16 |
Richard Miller | 13 |
Leiv Lea | 7 |
William Jones | 6 |
James Rosenbaum | 6 |
Suresh Mahabhashyam | 5 |
Gabriel Luciano | 4 |
- Bolsa de valores
- Insiders
- Jeffrey Arcara
- Conexiones Empresas